No Apparent Reduction in Schistosome Burden or Genetic Diversity Following Four Years of School-Based Mass Drug Administration in Mwea, Central Kenya, a Heavy Transmission Area

Figure 3

Mean changes in genetic diversity of schistosomes collected from humans before and after four years of an annual mass treatment program.

Lines indicate means. Data are corrected for sibling structure. A. allelic richness B. gene diversity.